Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19 vaccine for the 2024-2025 fall season...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoBuy? No, Novavax stock isn't a buy. Savvy investors are encouraged to buy a stock after it breaks...
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 6 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 5 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 6 days agoDo Vaccines Protect Against KP.3? Per Zambrano, all three COVID vaccine manufacturers—Pfizer,...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 5 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 6 days agoJust be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about 9% higher...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 2 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 4 days agoCOVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration ...